Lotus Eye Hospital and Institute Limited
NSE:LOTUSEYE.NS
69.89 (INR) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities: | |||||||||||||
Net Income
| 29.145 | 56.539 | 41.035 | 19.111 | 21.479 | 6.285 | 16.606 | 4.017 | -0.205 | -19.808 | 0.998 | 4.544 | -22.45 |
Depreciation & Amortization
| 37.278 | 29.805 | 25.01 | 23.301 | 24.965 | 30.588 | 33.71 | 34.412 | 44.34 | 47.388 | 35.106 | 37 | 39.983 |
Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change In Working Capital
| -2.108 | -20.415 | -7.449 | -6.623 | 12.684 | 11.94 | 12.165 | 1.619 | -8.885 | -0.972 | 4.135 | -2.411 | 5.91 |
Accounts Receivables
| -0.857 | -5.476 | 1.205 | -0.809 | 1.036 | 3.732 | -6.037 | -1.737 | -1.563 | 0.411 | -0.849 | 0.723 | 0 |
Inventory
| -4.21 | -4.853 | -5.258 | 3.333 | 0.425 | 2.336 | -5.907 | 9.829 | 3.04 | 5.52 | -4.878 | -10.484 | -4.361 |
Accounts Payables
| 3.836 | -4.112 | 3.563 | -0.624 | 2.454 | -8.699 | 13.142 | -8.078 | 0 | 0 | 0 | 0 | 0 |
Other Working Capital
| -0.877 | -5.974 | -6.959 | -8.523 | 8.769 | 14.571 | 18.072 | -8.21 | -11.925 | -6.492 | 9.013 | 8.073 | 10.271 |
Other Non Cash Items
| 72.307 | -22.058 | -14.656 | -8.398 | -10.985 | -6.832 | -4.7 | -2.817 | -1.824 | -2.84 | -2.991 | -1.984 | -0.623 |
Operating Cash Flow
| 60.835 | 43.871 | 43.94 | 27.391 | 48.143 | 41.981 | 57.781 | 37.231 | 33.426 | 23.768 | 37.248 | 37.149 | 22.82 |
Investing Activities: | |||||||||||||
Investments In Property Plant And Equipment
| -56.431 | -30.97 | -46.849 | -4.757 | -24.202 | -46.854 | -42.766 | -14.546 | -11.513 | -54.852 | -53.281 | -14.061 | -33.816 |
Acquisitions Net
| 0.734 | 0.092 | 0.195 | 3.552 | 9.944 | 0.096 | 0.765 | 0.322 | 0.464 | 0 | 0 | 0 | 0 |
Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Investing Activites
| 4.395 | 8.934 | 7.475 | 6.06 | 9.003 | 6.68 | 4.16 | 3.609 | 3.043 | 8.318 | 2.745 | 2.087 | 0.92 |
Investing Cash Flow
| -51.302 | -21.944 | -39.179 | 4.855 | -5.255 | -40.078 | -38.606 | -10.937 | -8.47 | -46.534 | -50.536 | -11.974 | -32.896 |
Financing Activities: | |||||||||||||
Debt Repayment
| -22.646 | -5.677 | -4.137 | -2.628 | -0.916 | -0.94 | -2.019 | -1.831 | -1.877 | -6.209 | -0.686 | -1.468 | 0 |
Common Stock Issued
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Dividends Paid
| -10.398 | -10.398 | -10.336 | 0 | 0 | -12.515 | -12.515 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing Activities
| -0.974 | -0.976 | -1.281 | -0.649 | 2.263 | -0.644 | -2.55 | -1.184 | -5.374 | 18.721 | -0.097 | -1.644 | 1.463 |
Financing Cash Flow
| -33.044 | -17.051 | -15.754 | -3.277 | 1.347 | -14.099 | -15.065 | -1.184 | -5.374 | 18.721 | -0.783 | -1.644 | 1.463 |
Other Information: | |||||||||||||
Effect Of Forex Changes On Cash
| 0 | 0 | -0.001 | 0 | -0.208 | 0 | -0.001 | 0 | 0 | -0.001 | 0 | 0 | 0 |
Net Change In Cash
| 33.54 | 4.876 | -10.994 | 28.969 | 44.235 | -12.196 | 4.109 | 25.11 | 19.582 | -4.046 | -14.071 | 23.531 | -8.613 |
Cash At End Of Period
| 70.404 | 92.806 | 87.93 | 98.924 | 70.163 | 25.928 | 38.124 | 49.847 | 24.737 | 5.155 | 9.201 | 23.272 | -0.259 |